Literature DB >> 19101523

Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism.

Xuebo Liu1, Takahiro Shibata, Shinsuke Hisaka, Toshihiko Osawa.   

Abstract

Astaxanthin is a powerful antioxidant that occurs naturally in a wide variety of living organisms. The aim of this study is to investigate the effect and the mechanism of astaxanthin on reactive oxygen species (ROS)-mediated apoptosis in dopaminergic SH-SY5Y cells. The treatment with DHA hydroperoxide (DHA-OOH) or 6-hydroxydopamine (6-OHDA), either of which is ROS-inducing neurotoxin, led to a significant decrease in viable dopaminergic SH-SY5Y cells by MTT assay, whereas a significant protection was shown while the cells were pretreated with astaxanthin. Moreover, 100 nM astaxanthin pretreatment significantly inhibited apoptosis, mitochondrial abnormalities and intracellular ROS generation occurred in either DHA-OOH- or 6-OHDA-treated cells. The neuroprotective effect of astaxanthin is suggested to be dependent upon its antioxidant potential and mitochondria protection; therefore, it is suggested that astaxanthin may be an effective treatment for oxidative stress-associated neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101523     DOI: 10.1016/j.brainres.2008.11.076

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  45 in total

1.  6-Hydroxydopamine-induced PC12 cell death is mediated by MEF2D down-regulation.

Authors:  Min-Kyoung Kim; Sang-Cheol Kim; Jung-Il Kang; Jae-Hee Hyun; Hye-Jin Boo; Su-Yong Eun; Deok-Bae Park; Eun-Sook Yoo; Hee-Kyoung Kang; Ji-Hoon Kang
Journal:  Neurochem Res       Date:  2010-11-06       Impact factor: 3.996

2.  Astaxanthin addition improves human neutrophils function: in vitro study.

Authors:  Rita C Macedo; Anaysa P Bolin; Douglas P Marin; Rosemari Otton
Journal:  Eur J Nutr       Date:  2010-04-02       Impact factor: 5.614

Review 3.  Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration.

Authors:  Bethany Grimmig; Seol-Hee Kim; Kevin Nash; Paula C Bickford; R Douglas Shytle
Journal:  Geroscience       Date:  2017-02-13       Impact factor: 7.713

4.  3,4,5-tri-O-caffeoylquinic acid inhibits amyloid β-mediated cellular toxicity on SH-SY5Y cells through the upregulation of PGAM1 and G3PDH.

Authors:  Yusaku Miyamae; Junkyu Han; Kazunori Sasaki; Mika Terakawa; Hiroko Isoda; Hideyuki Shigemori
Journal:  Cytotechnology       Date:  2011-03-19       Impact factor: 2.058

Review 5.  The Putative Role of Astaxanthin in Neuroinflammation Modulation: Mechanisms and Therapeutic Potential.

Authors:  Shuai Wang; Xin Qi
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 6.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

7.  Astaxanthin protects against MPP(+)-induced oxidative stress in PC12 cells via the HO-1/NOX2 axis.

Authors:  Qinyong Ye; Bixia Huang; Xiaodong Zhang; Yuangui Zhu; Xiaochun Chen
Journal:  BMC Neurosci       Date:  2012-12-29       Impact factor: 3.288

Review 8.  Astaxanthin: a potential therapeutic agent in cardiovascular disease.

Authors:  Robert G Fassett; Jeff S Coombes
Journal:  Mar Drugs       Date:  2011-03-21       Impact factor: 5.118

9.  Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops.

Authors:  Anton Lennikov; Nobuyoshi Kitaichi; Risa Fukase; Miyuki Murata; Kousuke Noda; Ryo Ando; Takeshi Ohguchi; Tetsuya Kawakita; Shigeaki Ohno; Susumu Ishida
Journal:  Mol Vis       Date:  2012-02-14       Impact factor: 2.367

Review 10.  Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease.

Authors:  Vyshnavy Balendra; Sandeep Kumar Singh
Journal:  Open Biol       Date:  2021-06-30       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.